A detailed history of Dgs Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dgs Capital Management, LLC holds 3,361 shares of ABBV stock, worth $604,980. This represents 0.19% of its overall portfolio holdings.

Number of Shares
3,361
Previous 2,990 12.41%
Holding current value
$604,980
Previous $512,000 29.49%
% of portfolio
0.19%
Previous 0.15%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 10, 2024

BUY
$163.84 - $199.33 $60,784 - $73,951
371 Added 12.41%
3,361 $663,000
Q2 2024

Dec 10, 2024

SELL
$154.79 - $180.76 $44,734 - $52,239
-289 Reduced 8.81%
2,990 $512,000
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $130,093 - $148,229
814 Added 33.02%
3,279 $597,000
Q4 2023

Jan 30, 2024

SELL
$137.6 - $154.97 $23,392 - $26,344
-170 Reduced 6.45%
2,465 $382,000
Q3 2023

Jan 30, 2024

BUY
$133.59 - $154.65 $30,458 - $35,260
228 Added 9.47%
2,635 $392,000
Q2 2023

Jan 30, 2024

SELL
$132.51 - $164.9 $397 - $494
-3 Reduced 0.12%
2,407 $324,000
Q1 2023

Jun 16, 2023

SELL
$144.61 - $166.54 $21,980 - $25,314
-152 Reduced 5.93%
2,410 $384,000
Q4 2022

Feb 21, 2023

BUY
$138.31 - $165.87 $17,980 - $21,563
130 Added 5.35%
2,562 $414,000
Q3 2022

Feb 21, 2023

BUY
$134.21 - $153.93 $25,902 - $29,708
193 Added 8.62%
2,432 $326,000
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $80,645 - $102,526
586 Added 35.45%
2,239 $343,000
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $218,162 - $270,678
1,653 New
1,653 $268,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dgs Capital Management, LLC Portfolio

Follow Dgs Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dgs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dgs Capital Management, LLC with notifications on news.